SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., developer of a new and disruptive DNA sequencing platform, today announced a collaboration and co-marketing partnership with Jumpcode Genomics ...
SAN DIEGO--(BUSINESS WIRE)--Element Biosciences, Inc., developer of the Element AVITI™ System, a new and disruptive DNA sequencing platform, today announced it has shipped multiple AVITI systems to ...
Single cell sequencing is a powerful technique for revealing hidden complexity within cell populations. The technique has found widespread adoption in fields such as immunology, neuroscience, and ...
Next-generation sequencing (NGS) has witnessed renewed excitement over the past couple years with several new platforms offering researchers unprecedented accuracy, speed, and flexibility. Launched in ...
/PRNewswire/ -- Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced it has exceeded 100 ...
Partnership combines QIAGEN's QIAseq panels, CLC LightSpeed, and QCI Interpret software to support Element's AVITI System users in genomic analysis Element and QIAGEN are advancing genomic ...
After raising $276 million in venture capital last year, Element Biosciences’ first DNA sequencing product is making its public debut. The company hopes to make a splash in a competitive market with ...
SAN DIEGO, Aug. 9, 2022 /PRNewswire/ -- Element Biosciences Inc., developer of the Element AVITI TM System, a new and disruptive DNA sequencing platform, announced today it will implement no price ...
/PRNewswire/ -- Element Biosciences, Inc., developer of the Element AVITI™ System, an innovative DNA sequencing platform that is disrupting the genomics industry, today announced it has exceeded 100 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results